Cargando…
Ciclesonide/iguratimod: Prolonged presence of SARS-CoV-2: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486151/ http://dx.doi.org/10.1007/s40278-020-83191-1 |
Ejemplares similares
-
Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide()
por: Baba, Hiroaki, et al.
Publicado: (2020) -
Molecular pharmacology of ciclesonide against SARS-CoV-2
por: Kimura, Hirokazu, et al.
Publicado: (2020) -
Development of ciclesonide analogues that block SARS-CoV-2 RNA replication
por: Tsuji, Genichiro, et al.
Publicado: (2021) -
Tacrolimus: Prolonged shedding of SARS-CoV-2: case report
Publicado: (2021) -
Bendamustine/ciclesonide/obinutuzumab: Diarrhoea following off-label use and prolonged viral shedding: case report
Publicado: (2021)